enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
enGene one of nine companies awarded CDRP per year Program aims to support CMC development of products with expedited clinical development timeframes and provide patients with earlier access to these products Detalimogene has already been manufactured at comm
(Financial Post, 2025-12-02T12:33:33Z)